A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment
Author:
Affiliation:
1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; Boston MA 02120 USA
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3616/fullpdf
Reference41 articles.
1. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009;Qureshi;Pharmacoepidemiol Drug Saf,2011
2. Failing the public health--rofecoxib, Merck, and the FDA;Topol;N Engl J Med,2004
3. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2;McGettigan;JAMA,2006
4. Early detection of adverse drug events within population-based health networks: application of sequential testing methods;Brown;Pharmacoepidemiol Drug Saf,2007
5. You can observe a lot (about medical products) by watching (those who use them);Gagne;Epidemiology,2013
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prospective Monitoring of New Drugs in Older Adults with and without Frailty: Near-Real-Time Assessment of Effectiveness and Safety of Oral Anticoagulants in Medicare Data;Drugs & Aging;2024-09-11
2. Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data;Drugs & Aging;2024-07
3. A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness;Journal of Clinical Epidemiology;2024-05
4. The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies;American Journal of Epidemiology;2023-10-17
5. Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data;Drug Safety;2021-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3